Union Bancaire Privee UBP SA Buys Shares of 5,485 iShares Biotechnology ETF (NASDAQ:IBB)

Union Bancaire Privee UBP SA bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 5,485 shares of the financial services provider’s stock, valued at approximately $693,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in IBB. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at $29,000. Highline Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $30,000. HHM Wealth Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after buying an additional 150 shares during the period. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $36,000. Finally, Newbridge Financial Services Group Inc. purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at $33,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.1 %

IBB stock opened at $138.74 on Tuesday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The business’s fifty day moving average price is $135.64 and its 200 day moving average price is $140.77.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.